Zobrazeno 1 - 10
of 36
pro vyhledávání: '"John, Hawboldt"'
Publikováno v:
JMIR Biomedical Engineering, Vol 6, Iss 4, p e26556 (2021)
BackgroundThe majority of medications used in treating asthma and chronic obstructive pulmonary disease (COPD) are taken through metered-dose inhalers (MDIs). Studies have reported that most patients demonstrate poor inhaler technique, which has resu
Externí odkaz:
https://doaj.org/article/5535e4d38b384008a661616b9d783c08
Autor:
Meshari F. Alwashmi, Beverly Fitzpatrick, Erin Davis, Jamie Farrell, John-Michael Gamble, John Hawboldt
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Background: The use of mobile health (mHealth) interventions has the potential to enhance chronic obstructive pulmonary disease (COPD) treatment outcomes. Further research is needed to determine which mHealth features are required to potentially enha
Externí odkaz:
https://doaj.org/article/52147e7b6aff4028a5555b07d6487eba
Publikováno v:
Global Pediatric Health, Vol 4 (2017)
Low adherence to cystic fibrosis (CF) treatment is associated with poor health outcomes, while knowledge of the disease and medication regimen can positively influence adherence. This study’s purpose was to develop and validate a questionnaire to h
Externí odkaz:
https://doaj.org/article/d5c9498b7cfd47e5be24e1bb49a9cbf2
Autor:
Mazen S. Bader, Dominik Mertz, John Hawboldt, Alison Farrell, Abdulaziz Alajmi, Keon Maleki-Yazdi
Publikováno v:
Infectious Diseases in Clinical Practice. 30
Autor:
Annie Brooks, Neal Irfan, Dominik Mertz, Mazen S. Bader, Yasmeen Marbaniang Vincent, Alison Farrell, John Hawboldt
Publikováno v:
Infectious Diseases. 53:255-273
Diabetic foot is one of the common complications of diabetes mellitus. We report clinical and microbiological characteristics and outcomes of cases with distant metastatic foci of infection arising from diabetic foot.Retrospective review of adult pat
Autor:
Alison Farrell, John Hawboldt, Mazen S. Bader, Joanna Joyce, Mark Loeb, Cheryl Main, Dominik Mertz
Publikováno v:
Infectious Diseases. 52:847-857
Guidelines recommend oral vancomycin as first-line therapy for Clostridioides difficile infection. Guideline recommendations vary regarding dosing of vancomycin. Our aim was to summarize the curren...
Publikováno v:
Pharmacy, Vol 5, Iss 1, p 14 (2017)
International standards of pharmacy curricula are necessary to ensure student readiness for international placements. This paper explores whether curricula from two pharmacy programs, in Australia and Canada, are congruent with international standard
Externí odkaz:
https://doaj.org/article/628dcf2af75147ce9edc925711919efe
Autor:
Erin Davis, Meshari F Alwashmi, Jamie Farrell, John-Michael Gamble, John Hawboldt, Beverly FitzPatrick
Publikováno v:
Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Background: The use of mobile health (mHealth) interventions has the potential to enhance chronic obstructive pulmonary disease (COPD) treatment outcomes. Further research is needed to determine which mHealth features are required to potentially enha
Autor:
Mazen S, Bader, John, Hawboldt, Cheryl, Main, Dominik, Mertz, Mark, Loeb, Alison, Farrell, Joanna, Joyce
Publikováno v:
Infectious diseases (London, England). 52(12)
Guidelines recommend oral vancomycin as first-line therapy forWe searched clinical studies and major guidelines in the English language using MEDLINE, the Cochrane Library and Embase from 1985 until 15 April 2020.No evidence supports the use of high
Autor:
Meshari F Alwashmi, John Hawboldt, Gerard Farrell, Hai V. Nguyen, Erin Davis, Beverly FitzPatrick, John-Michael Gamble, Jamie Farrell
Publikováno v:
JMIR mHealth and uHealth, Vol 8, Iss 7, p e17409 (2020)
JMIR mHealth and uHealth
JMIR mHealth and uHealth
Background Using a mobile health (mHealth) intervention consisting of a smartphone and compatible medical device has the potential to enhance chronic obstructive pulmonary disease (COPD) treatment outcomes while mitigating health care costs. Objectiv